Skip to main content

Exact Sciences Corp

EXASDelisted Mar 23, 2026
Industry
Services-Medical Laboratories
SEC CIK
0001124140

Exact Sciences Corp was delisted on Mar 23, 2026; its insiders filed their last Form 4 on Mar 23, 2026; 712 institutions reported holding it in 13F filings for Q4 2025, worth $17.9B in total; superinvestors Soros Fund Management and ARK Invest held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Exact Sciences Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Exact Sciences Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Exact Sciences Corp
NameTitleLast reported holdingLast filingFilings, past year
Coward D ScottDirector0IndirectMar 23, 20261
Orville Jacob AEVP, GM, Screening0IndirectMar 23, 20264
Trigg LeslieDirector0Mar 23, 20261
Conroy Kevin TPresident and CEO0IndirectMar 23, 20264
Popovits Kimberly JDirector0Mar 23, 20261
Zanotti Katherine SDirector0Mar 23, 20262
Clancy Paul JDirector0Mar 23, 20261
Doyle James EdwardDirector0Mar 23, 20262
Petrovic ShaceyDirector0IndirectMar 23, 20261
Condella SarahEVP, Human Resources0IndirectMar 23, 20264
Barber Michael JDirector0Mar 23, 20261
Baranick BrianEVP, GM, Precision Oncology0IndirectMar 23, 20264
Herriott JamesSVP, General Counsel & Sec0IndirectMar 23, 20266
Bloomer AaronEVP, Chief Financial Officer0IndirectMar 23, 20263
Levangie Daniel JDirector34,312Jun 16, 20250
Sebelius KathleenDirector32,671Dec 20, 20240
Cunningham EverettChief Commercial Officer47,042May 2, 20240
Elliott Jeffrey ThomasChief Financial Officer11,795May 2, 20240
Scannell Timothy JDirector5,694Nov 1, 20230
Lewis-Hall Freda CDirector19,688Jun 12, 20230
Jacquet PierreDirector23,576Jun 12, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 22, 2024 (view filing)Feb 211 dayElliott Jeffrey ThomasChief Financial OfficerSSale−1.49K$61.50−$91.8K−28.7%3.70K after10b5-1
Feb 22, 2024 (view filing)Feb 211 dayCoward D ScottDirectorSSale−706$61.50−$43.4K−1.6%43.1K after10b5-1
Feb 22, 2024 (view filing)Feb 211 dayConroy Kevin TPresident and CEOSSale−4.97K$61.50−$306.0K−0.4%1.23M after10b5-1
Feb 22, 2024 (view filing)Feb 211 dayCondella SarahEVP, Human ResourcesSSale−1.08K$61.50−$66.4K−1.5%71.7K after10b5-1
Feb 22, 2024 (view filing)Feb 211 dayBaranick BrianGen. Mgr., Precision OncologySSale−895$61.50−$55.0K−9.2%8.83K after10b5-1
Feb 16, 2024 (view filing)Feb 151 dayOrville Jacob AGeneral Manager, ScreeningSSale−966$61.43−$59.3K−11.4%7.49K after10b5-1
Feb 16, 2024 (view filing)Feb 151 dayHerriott JamesGeneral CounselSSale−421$61.43−$25.9K−6.1%6.49K after10b5-1
Feb 16, 2024 (view filing)Feb 151 dayElliott Jeffrey ThomasChief Financial OfficerSSale−1.89K$61.43−$116.0K−47.5%2.08K after10b5-1
Feb 16, 2024 (view filing)Feb 151 dayCoward D ScottDirectorSSale−1.38K$61.43−$84.5K−3.2%41.6K after10b5-1
Feb 16, 2024 (view filing)Feb 151 dayConroy Kevin TPresident and CEOSSale−14.8K$61.43−$908.6K−1.2%1.22M after10b5-1
Feb 16, 2024 (view filing)Feb 151 dayCondella SarahEVP, Human ResourcesSSale−965$61.43−$59.3K−1.4%70.5K after10b5-1
Jan 4, 2024 (view filing)Jan 22 daysCondella SarahEVP, Human ResourcesSSale−2.00K$73.50−$147.0K−2.8%69.4K after10b5-1
Jan 4, 2024 (view filing)Jan 22 daysBaranick BrianGen. Mgr., Precision OncologySSale−879$73.50−$64.6K−9.9%7.99K after10b5-1
Dec 18, 2023 (view filing)Dec 144 daysCondella SarahEVP, Human ResourcesSSale−2.00K$70.00−$140.0K−2.7%71.4K after10b5-1
Oct 13, 2023 (view filing)Oct 121 dayCunningham EverettChief Commercial OfficerSSale−13.0K$66.49−$864.8K−25.5%37.9K after
Sep 6, 2023 (view filing)Sep 15 daysCondella SarahEVP, Human ResourcesSSale−4.50K$84.36−$379.6K−5.6%75.8K after10b5-1
Aug 23, 2023 (view filing)Aug 212 daysElliott Jeffrey ThomasChief Financial OfficerSSale−30.2K$82.92−$2.51M−100.0%0 after10b5-1
Aug 8, 2023 (view filing)Aug 71 dayBaranick BrianGen. Mgr., Precision OncologySSale−1.35K$85.04−$114.8K−13.2%8.87K after10b5-1
Jul 28, 2023 (view filing)Jul 271 dayDoyle James EdwardDirectorSSale−2.00K$97.42−$194.8K−3.7%52.1K after10b5-1
Jul 21, 2023 (view filing)Jul 192 daysHerriott JamesGeneral CounselSSale−1.30K$100.00−$130.0K−17.9%5.96K after10b5-1
Jun 12, 2023 (view filing)Jun 93 daysDoyle James EdwardDirectorSSale−1.40K$90.51−$126.9K−2.5%54.1K after10b5-1
Jun 12, 2023 (view filing)Jun 93 daysZanotti Katherine SDirectorSSale−3.03K$90.51−$274.0K−4.5%64.6K after10b5-1
Jun 12, 2023 (view filing)Jun 84 daysHerriott JamesGeneral CounselSSale−1.30K$90.00−$117.0K−15.2%7.26K after10b5-1
May 31, 2023 (view filing)May 265 daysDoyle James EdwardDirectorSSale−2.00K$80.62−$161.2K−3.7%51.9K after10b5-1
May 12, 2023 (view filing)May 102 daysCondella SarahEVP, Human ResourcesSSale−6.09K$80.00−$487.0K−7.0%80.3K after10b5-1
May 12, 2023 (view filing)May 102 daysOrville Jacob AGeneral Manager, ScreeningSSale−5.00K$80.00−$400.0K−43.8%6.42K after10b5-1
May 12, 2023 (view filing)May 102 daysHerriott JamesGeneral CounselSSale−1.30K$79.85−$103.8K−13.2%8.56K after10b5-1
May 3, 2023 (view filing)May 12 daysCondella SarahEVP, Human ResourcesSSale−1.00K$63.78−$63.8K−1.1%86.4K after10b5-1
Apr 5, 2023 (view filing)Apr 32 daysCondella SarahEVP, Human ResourcesSSale−1.00K$67.19−$67.2K−1.1%86.7K after10b5-1
Mar 7, 2023 (view filing)Mar 34 daysOrville Jacob AGeneral Manager, ScreeningSSale−5.00K$65.00−$325.0K−30.4%11.4K after
Mar 2, 2023 (view filing)Mar 11 dayCunningham EverettChief Commercial OfficerSSale−3.63K$62.01−$225.0K−13.8%22.7K after
Mar 2, 2023 (view filing)Mar 11 dayCondella SarahEVP, Human ResourcesSSale−1.00K$62.00−$62.0K−1.1%87.7K after
Mar 1, 2023 (view filing)Feb 281 dayElliott Jeffrey ThomasChief Financial OfficerSSale−4.23K$61.12−$258.7K−12.6%29.2K after
Mar 1, 2023 (view filing)Feb 281 dayHerriott JamesGeneral CounselSSale−2.23K$60.43−$134.5K−19.4%9.22K after2 lots
Mar 1, 2023 (view filing)Feb 281 dayOrville Jacob AGeneral Manager, ScreeningSSale−6.83K$60.29−$411.9K−29.4%16.4K after2 lots
Mar 1, 2023 (view filing)Feb 281 dayCoward D ScottDirectorSSale−4.15K$61.12−$253.8K−11.2%32.8K after
Mar 1, 2023 (view filing)Feb 281 dayCondella SarahEVP, Human ResourcesSSale−2.92K$61.12−$178.7K−3.2%88.7K after
Mar 1, 2023 (view filing)Feb 281 dayBaranick BrianGen. Mgr., Precision OncologySSale−1.93K$61.12−$118.1K−20.5%7.51K after
Mar 1, 2023 (view filing)Feb 281 dayConroy Kevin TPresident and CEOSSale−10.4K$61.12−$636.6K−0.9%1.21M after
Feb 23, 2023 (view filing)Feb 221 dayConroy Kevin TPresident and CEOSSale−4.76K$62.72−$298.8K−0.4%1.20M after
Feb 23, 2023 (view filing)Feb 221 dayHerriott JamesGeneral CounselSSale−398$62.72−$25.0K−4.0%9.56K after
Feb 23, 2023 (view filing)Feb 221 dayOrville Jacob AGeneral Manager, ScreeningSSale−2.71K$62.72−$170.0K−12.3%19.3K after
Feb 23, 2023 (view filing)Feb 221 dayCondella SarahEVP, Human ResourcesSSale−1.03K$62.72−$64.8K−1.2%85.3K after
Feb 23, 2023 (view filing)Feb 221 dayCoward D ScottDirectorSSale−1.01K$62.72−$63.2K−3.5%27.7K after
Feb 23, 2023 (view filing)Feb 221 dayElliott Jeffrey ThomasChief Financial OfficerSSale−1.43K$62.72−$89.7K−5.5%24.3K after
Feb 23, 2023 (view filing)Feb 221 dayBaranick BrianGen. Mgr., Precision OncologySSale−838$62.72−$52.6K−13.2%5.49K after
Feb 17, 2023 (view filing)Feb 161 dayCondella SarahEVP, Human ResourcesSSale−1.08K$63.91−$68.8K−1.3%84.1K after
Feb 16, 2023 (view filing)Feb 151 dayHerriott JamesGeneral CounselSSale−400$65.59−$26.2K−4.2%9.10K after
Feb 16, 2023 (view filing)Feb 151 dayCondella SarahEVP, Human ResourcesSSale−954$65.59−$62.6K−1.1%85.2K after
Feb 16, 2023 (view filing)Feb 151 dayOrville Jacob AGeneral Manager, ScreeningSSale−954$69.59−$66.4K−5.6%16.1K after